Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1381861-91-1
1393330-41-0
1415800-38-2
1623792-00-6
782475-37-0
1807503-92-9
1370698-27-3 | Aminooxy-peg7-methane | AA019E3U | MFCD29918214
2093154-02-8 | N-Boc-n-bis(peg4-oh) | AA019E7E | MFCD30536157
1596368-98-7 | (1,3-dioxoisoindolin-2-yl)-PEG2-Boc | AA019EC4 | MFCD31380401
2006345-32-8 | BDP TMR alkyne | AA019EG3 | MFCD31580107
882660-42-6 | trans-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanamine trihydrochloride | AA019EJO | MFCD13185107
1784807-21-1 | tert-Butyl 7-oxo-3,6-diazabicyclo[3.2.2]nonane-3-carboxylate | AA019EML | MFCD28534913
86255-43-8 | 1,3-dimethoxy-5-[(E)-2-nitroethenyl]benzene | AA019EPZ | MFCD00031526
851870-30-9 | 5-Iodo-1-methyl-2-phenyl-1H-imidazole | AA019EST | MFCD28399099
230618-42-5 | 2-Bromo-4-(pyrrolidin-1-yl)pyridine | AA019EWD | MFCD09032268
1276541-99-1 | 3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID | AA019EZ4 | MFCD17193828
